Patient engagement through advisory boards, surveys, and listening sessions can help address industry challenges such as trial delays.

The recent reductions in the US Food and Drug Administration’s workforce are poised to have a substantial impact on drug and biologic ...

“This is a really exciting new area that has tremendous potential to assist drug discovery and development,” says Koguchi. “It’s creating new avenues of research that were never before ...

| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

The 'me-too' drug problem For example ... therapies is by far the biggest value-added step in pharmaceutical research and development. By allowing reach-through claims to the inventors of those ...